Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections

Tibor Bakacs; Konstantin Chumakov; Rifaat Safadi; Imre Kovesdi

doi:10.3389/fimmu.2022.1046851

Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections

Front Immunol. 2022 Oct 6:13:1046851. doi: 10.3389/fimmu.2022.1046851. eCollection 2022.

Authors

Tibor Bakacs¹, Konstantin Chumakov², Rifaat Safadi³, Imre Kovesdi⁴

Affiliations

¹ Department of Probability, Alfred Renyi Institute of Mathematics; The Eötvös Loránd Research Network (ELKH), Budapest, Hungary.
² Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, United States.
³ Hadassah Medical School, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
⁴ Unleash Immuno Oncolytics, St. Louis, MO, United States.

No abstract available

Keywords: COVID-19 vaccine; attenuated viruses; controlled field trials; double-stranded RNA (dsRNA); intentional viral coinfection; interferon (IFN) system; molnupiravir and paxlovid; superinfection therapy (SIT).

Publication types

Editorial

MeSH terms

RNA, Double-Stranded*
RNA, Viral
Viruses*

Substances

RNA, Double-Stranded
RNA, Viral